Clinical Trial Update: Interferon α2a Versus Cyclosporine for Refractory Behçet's Disease Uveitis [Phase 3]

View source ↗

Summary

A Phase 3 trial comparing Interferon α2a to Cyclosporine for refractory Behçet's disease uveitis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Behçet Disease
• Uveitis

Drugs mentioned

• CYCLOSPORINE (cyclosporine)
• Interferon alfa-2a (interferon alfa-2a)

Snippet

Sponsor: Peking Union Medical College Hospital | Conditions: Behçet Disease, Uveitis | Phase 3 | Status: COMPLETED